BioCentury
ARTICLE | Company News

Draxis, Molecular Targeting deal

November 15, 1999 8:00 AM UTC

DRAX’s Draximage Inc. subsidiary (Kirkland, Quebec) received exclusive worldwide rights outside specified countries in southeast Asia to manufacture and sell Molecular Targeting’s Amiscan formulation...